BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32524704)

  • 1. Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS study.
    Adam S; Martin-Diener E; Camey B; Egger Hayoz C; Konzelmann I; Mohsen Mousavi S; Herrmann C; Rohrmann S; Wanner M; Staehelin K; Strebel RT; Randazzo M; John H; Schmid HP; Arndt V
    Cancer Med; 2020 Aug; 9(15):5416-5424. PubMed ID: 32524704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study.
    Adam S; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Pritzkuleit R; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Rohrmann S; Brenner H; Arndt V
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13076. PubMed ID: 31050091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.
    Eisemann N; Nolte S; Schnoor M; Katalinic A; Rohde V; Waldmann A
    BMC Urol; 2015 Apr; 15():28. PubMed ID: 25885890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors-results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS).
    Adam S; Thong MSY; Martin-Diener E; Camey B; Egger Hayoz C; Konzelmann I; Mousavi SM; Herrmann C; Rohrmann S; Wanner M; Staehelin K; Strebel RT; Randazzo M; John H; Schmid HP; Feller A; Arndt V
    Support Care Cancer; 2021 Nov; 29(11):6259-6269. PubMed ID: 33847829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls-results from a population-based study.
    Adam S; Doege D; Koch-Gallenkamp L; Thong MSY; Bertram H; Eberle A; Holleczek B; Pritzkuleit R; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Jansen L; Rohrmann S; Brenner H; Arndt V
    Support Care Cancer; 2020 Jun; 28(6):2875-2885. PubMed ID: 31736000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery.
    Suardi N; Moschini M; Gallina A; Gandaglia G; Abdollah F; Capitanio U; Bianchi M; Tutolo M; Passoni N; Salonia A; Hedlund P; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2013 May; 111(5):717-22. PubMed ID: 22726993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual Rehabilitation After Nerve-Sparing Radical Prostatectomy: Free-of-Charge Phosphodiesterase Type 5 Inhibitor Administration Improves Compliance to Treatment.
    Siena G; Mari A; Canale A; Mondaini N; Chindemi A; Greco I; Saleh O; Serni S; Nicita G; Minervini A; Carini M
    J Sex Med; 2018 Feb; 15(2):120-123. PubMed ID: 29425663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors.
    Kurian CJ; Leader AE; Thong MSY; Keith SW; Zeigler-Johnson CM
    BMC Public Health; 2018 Aug; 18(1):1060. PubMed ID: 30139347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' desire to preserve sexual activity and final decision for a nerve-sparing approach: results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study.
    Imbimbo C; Creta M; Gacci M; Simonato A; Gontero P; de Cobelli O; Briganti A; Fulcoli V; Martorana G; Nicita G; Mirone V; Carmignani G
    J Sex Med; 2011 May; 8(5):1495-502. PubMed ID: 21324091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.
    Drummond FJ; Kinnear H; O'Leary E; Donnelly ; Gavin A; Sharp L
    J Cancer Surviv; 2015 Jun; 9(2):361-72. PubMed ID: 25563819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of positive surgical margins after biopsy-selected nerve-sparing radical prostatectomy.
    Graefen M; Hammerer P; Michl U; Noldus J; Haese A; Henke RP; Huland E; Huland H
    Urology; 1998 Mar; 51(3):437-42. PubMed ID: 9510349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre study.
    Furrer MA; Sathianathen N; Gahl B; Corcoran NM; Soliman C; Rodriguez Calero JA; Ineichen GB; Gahl M; Kiss B; Thalmann GN
    BJU Int; 2024 Jan; 133(1):53-62. PubMed ID: 37548822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.
    Meissner VH; Herkommer K; Marten-Mittag B; Gschwend JE; Dinkel A
    J Cancer Surviv; 2017 Dec; 11(6):800-807. PubMed ID: 28528448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy.
    Harris CR; Punnen S; Carroll PR
    J Urol; 2013 Sep; 190(3):981-6. PubMed ID: 23410984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and Long-term Functional Outcomes and Quality of Life after Radical Prostatectomy: Patient-reported Outcomes from a Tertiary High-volume Center.
    Pompe RS; Tian Z; Preisser F; Tennstedt P; Beyer B; Michl U; Graefen M; Huland H; Karakiewicz PI; Tilki D
    Eur Urol Focus; 2017 Dec; 3(6):615-620. PubMed ID: 28869202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nerve-sparing radical prostatectomy--effect and risks].
    Borre M
    Ugeskr Laeger; 2008 Aug; 170(34):2549-54. PubMed ID: 18761837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
    Lunger L; Meissner VH; Kopp BCG; Dinkel A; Schiele S; Ankerst DP; Gschwend JE; Herkommer K
    BMC Urol; 2023 Aug; 23(1):139. PubMed ID: 37612591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.